Xenon Pharmaceuticals Inc
Symbol: XENE (NASDAQ)
37.52
▼ (-6.55%) -2.629
Company Description:
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Key Stats
- Today's Open: $39.97
- Today's High: $40.595
- Today's Low: $37.521
- Today's Volume: 1.23M
- Yesterday Close: $40.15
- Yesterday High: $40.355
- Yesterday Low: $38.3236
- Yesterday Volume: 1.24M
- Last Min Volume: 0
- Last Min High: $37.541
- Last Min Low: $37.521
- Last Min VWAP: $0
Company Profile
- Name: Xenon Pharmaceuticals Inc
- Website: https://www.xenon-pharma.com
- Listed Date: 2014-11-05
- Location: BURNABY,
- Market Status: Active
- CIK Number: 0001582313
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $3.10B
- Round Lot: 100
- Outstanding Shares: 77.11M
- Asset Type: CS
RECENT FILINGS FOR XENE
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-19 | 144 | View |
| 2025-08-12 | SCHEDULE 13G/A | View |
| 2025-08-11 | 10-Q | View |
| 2025-08-11 | 8-K | View |
| 2025-08-06 | SCHEDULE 13G/A | View |
| 2025-07-17 | SCHEDULE 13G | View |
| 2025-07-03 | 8-K | View |
| 2025-06-24 | 4 | View |
| 2025-06-24 | 3 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-05 | 8-K | View |
| 2025-05-16 | 4 | View |
| 2025-05-12 | 10-Q | View |
| 2025-05-12 | 8-K | View |
Latest News on XENE